OCBC 1HFY2025 net profit falls 6% y-o-y to $3.7 bil
Oversea-Chinese Banking Corporation (OCBC) has reported net profit of $3.70 billion for 1HFY2025 ended June 30, 6% lower y-o-y.
Total income during the period slipped 1% y-o-y to $7.2 billion, with a 5% drop in net interest income (NII) compensated by fee and trading income growth, as non-interest income rose 8% y-o-y.
Net interest margin (NIM) declined by 25 basis points (bps) to 1.98%, as the drop in asset yields outpaced the decrease in funding costs.
Meanwhile, insurance income from Great Eastern Holdings (GEH) declined by 9% y-o-y, largely attributable to the mark-to-market impact of decline in interest rates on the valuation of insurance contract liabilities, as well as lower valuation of private equity holdings, from its insurance funds.
New business embedded value (NBEV) increased by 16% y-o-y and NBEV margin rose to 44.7% from 28.0% a year ago, driven by improved insurance product mix, according to OCBC.
Operating expenses were $2.80 billion, up 3% from the previous year. Staff costs were 4% higher y-o-y, attributable to annual salary increments and increased variable compensation linked to higher business activities.
Cost-to-income ratio was maintained below 40%, and higher credit allowances were set aside in view of the current uncertain operating environment, says the bank on Aug 1. Total allowances rose 4% y-o-y to S$326 million, mainly due to an increase in allowances for nonimpaired assets.
Asset quality remained benign with non-performing loan (NPL) ratio at 0.9%, while allowance coverage for total non-performing assets (NPA) stood at 156%.
The group's annualised return on equity was 12.6%, lower than 14.5% in 1HFY2024, while annualised earnings per share was $1.64, 6% lower y-o-y.
OCBC has declared an interim ordinary dividend of 41 cents per share, representing a payout ratio of 50% of 1HFY2025 group net profit. This is lower than an interim dividend of 44 cents per share this time last year.
OCBC says it remains committed to the previously announced $2.5 billion capital return, which includes a special dividend amounting to 10% of FY2025 group net profit and share buybacks over two years, to be completed in 2026.
Together with OCBC's target 50% ordinary dividend payout ratio, this represents a total dividend payout ratio of 60% for FY2025.
During 2QFY2025, OCBC posted group net profit of $1.82 billion, 7% lower q-o-q and 4% lower q-o-q. This was slightly below Bloomberg consensus estimates of $1.84 billion.
NII fell 6% y-o-y and 3% q-o-q to $2.28 billion, as a 2% increase in average assets was more than offset by a 12 bps q-o-q contraction in NIM to 1.92%.
According to OCBC, the NIM decline was largely associated with the downward repricing of Singapore dollar- and Hong Kong dollar-denominated loans, as a result of the significant drop in the benchmark rates this year, which outpaced the reduction in deposit costs.
The strategic deployment of liquidity into income-accretive high-quality assets in 1QFY2025 also weighed on NIM, says OCBC.
Non-interest income rose 5% y-o-y but fell 4% q-o-q to $1.26 billion, driven by lower insurance and trading income, which were partly compensated by higher fee income and net realised gains from the sale of investment securities.
Operating expenses increased 1% y-o-y but declined 2% q-o-q to $1.39 billion for the quarter, while total allowances were down 46% q-o-q. Credit costs were an annualised 12 bps, below the 24 bps reported in 1QFY2025.
The cost-to-income ratio for the quarter was 39.1%.
Total NPAs as at June 30 were $3.01 billion, up 4% y-o-y and 3% q-o-q, mainly due to new NPA formation. OCBC says this was partly compensated by net recoveries and upgrades, write-offs and the effect of foreign currency translation.
Meanwhile, the NPL ratio was stable at 0.9%, and total NPA coverage was 156%.
As at June 30, customer loans were $325 billion, up 9% y-o-y and 3% q-o-q on a constant currency basis. OCBC says this was driven by housing loan growth in Singapore and higher non-trade corporate lending, as the bank continued to support customers in the infrastructure, data centres and transportation sectors.
Meanwhile, sustainable financing loans grew 19% y-o-y to $53.1 billion as at June 30, and made up 16% of group loans, while total commitments stood at $74.3 billion.
Customer deposits increased 10% y-o-y to $407 billion, primarily driven by current account and savings account (casa) deposit growth across both corporate and consumer segments.
OCBC's loan-to-deposit ratio was 78.7% as at June 30, broadly unchanged as compared to 78.9% at the end of the prior quarter.
Finally, the group's common equity tier-1 (CET-1) capital adequacy ratio (CAR) is subject to the Monetary Authority of Singapore's final Basel III reforms requirements, which came into effect on July 1, 2024 and are being progressively phased in until Jan 1, 2029.
OCBC's group CET-1 CAR as at June 30 was 17.0%, and on a fully phased-in basis, it was 15.3%. This is down from 17.6% and 15.5% respectively at March 31.
Outgoing group CEO Helen Wong says the 1HFY2025 results reflected 'resilient performance' across a diversified business franchise. 'We expanded our loan book and maintained sound asset quality, and delivered broad-based fee income growth. Underpinned by our strong balance sheet and capital position, we are firmly committed to our comprehensive capital return plan.'
Wong adds: 'Over the past year, we have met our objectives of increasing our economic interests in GEH and have also assisted GEH in managing the trading suspension of its shares. As we move forward, we will continue to derive more synergies within the group, and are confident that this will further our drive to be a leading wealth management player in the region.'
The outlook ahead remains challenging. Evolving trade and monetary policies, and persistent geopolitical tensions are expected to weigh on growth prospects, says Wong, who is set to retire at the end of the year. 'Despite the uncertainties, OCBC has a strong and resilient franchise. As I prepare to hand over the reins of group CEO to Teck Long's capable hands on Jan 1, 2026, I do so with full confidence. OCBC is well-placed for the future with a clear ambition, and we are focused on supporting our customers and capturing growth opportunities across the region to drive long-term value for our stakeholders.'
Shares in OCBC closed 17 cents lower, or 1% down, at $16.87 on July 31.
See Also:
Click here to stay updated with the Latest Business & Investment News in Singapore
Dividend surprises 'unlikely' in 2QFY2025 for Singapore banks, says Maybank
Will the Fed be politically pressured to cut interest rates soon?
Brokers' Digest: OCBC, Sembcorp, Genting Singapore, Frencken, ESR-REIT
Read more stories about where the money flows, and analysis of the biggest market stories from Singapore and around the World
Get in-depth insights from our expert contributors, and dive into financial and economic trends
Follow the market issue situation with our daily updates
Or want more Lifestyle and Passion stories? Click here
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Inbank unaudited financial results for Q2 and 6 months of 2025
In Q2 2025, Inbank delivered record-breaking sales with an originated volume of 196 million euros, representing a 15% year-on-year increase. In the same period, Inbank earned a consolidated net profit of 3.6 million euros, declining 6% year-on-year. Net profit for the first half of 2025 was 8.1 million euros, which is 5% more than a year ago. The return on equity was 9.3% in Q2 and 10.8% for the half year of 2025. Inbank's total net income for the second quarter reached 20.7 million euros, increasing 8.4% year-on-year. Income from core activities, excluding financial and other income, grew by 15.3% to 21.1 million euros compared to 18.3 million euros year-on-year. Total operating expenses amounted to 11.6 million euros, which is a 7.1% increase year-on-year. As a result, Inbank's cost / income ratio improved to 55.9% for the quarter. In Q2 2025, Inbank delivered record-breaking sales with an originated volume of 196 million euros, which is 15% more than a year ago. The strong performance was primarily driven by high demand for green financing products in Poland and record-high direct lending volumes across all Inbank markets. Green financing grew 86% compared to a year ago and reached 36.9 million euros during the quarter. Direct lending grew by 44%, reaching 32.1 million euros. Merchant solutions remained Inbank's largest segment, with sales reaching 66.5 million euros, an increase of 3%. Car financing reached 47.1 million euros, showing signs of recovery following a challenging Q1, though remaining 10% below year-on-year. Rental services delivered 13.1 million euros, marking a 25% increase year-on-year. The loan and rental portfolio reached 1.21 billion euros increasing 11.2% year-on-year, while the deposit portfolio grew by 4.9% to 1.23 billion euros. As of the end of Q2, Inbank's total assets stood at 1.5 billion euros growing 5% year-on-year. Impairments on loans and receivables increased by 18.1% to 4.9 million euros and accounted for 1.64% of the average loan and rental portfolio, slightly exceeding our target. However, for the first half of the year, impairments remained within target at 1.59% By the end of Q2, the number of active customer contracts reached 931,000 and 5,700 active partners. Priit Põldoja, CEO, comments on the results: 'In the first half of 2025, Inbank's growth has been more measured. While we achieved a record high originated volume this quarter and are likely to surpass it in coming periods, we have maintained a disciplined approach to growth opportunities. Inbank's market share continues to expand across the Baltics. By the end of 2024, we reached 20.3% market share in consumer lending in Estonia. As interest rates decline, our margins continue to improve. However, to continue on our profitable growth path, we need to explore new niches in a €50bn Polish consumer finance market beyond our successful solar panel business and build our presence in Czechia. The last quarter marked a step in that direction, with record sales of 78 million euros in the Central and Eastern Europe (CEE) region. Inbank continues to grow not only geographically, but also by expanding its product offerings. In the last quarter, we launched payment protection insurance in Latvia and Lithuania, completing our presence with this product across all Baltic countries. Expanding our range of fee-based products for our large customer base remains an important strategic focus for Inbank. In early Q2, Inbank strengthened its Supervisory Board by appointing Erkki Raasuke as independent Chairman and welcoming two new members: Isabel Faragalli, a seasoned debt capital markets professional, and Sergei Anikin, an experienced tech leader. We look forward to working with the new Board to drive Inbank's European embedded finance growth strategy in the years ahead.' Key financial indicators as of 30.06.2025Total assets EUR 1.50 billion Loan and rental portfolio EUR 1.21 billionCustomer deposits EUR 1.23 billionTotal equity EUR 156 millionNet profit EUR 3.6 millionReturn on equity 9.3% Consolidated income statement (in thousands of euros) Q2 2025 Q2 2024 6 months 2025 6 months 2024 Interest income calculated using effective interest method 31,766 29,308 63,039 58,076 Interest expense -13,295 -13,072 -26,608 -26,684 Net interest income 18,471 16,236 36,431 31,392 Fee and commission income 15 106 22 217 Fee and commission expenses -881 -1,183 -2,113 -2,369 Net fee and commission income/expenses -866 -1,077 -2,091 -2,152 Rental income 9,524 8,159 18,673 15,308 Sale of assets previously rented to customers 4,307 3,539 8,268 8,122 Other operating income 8 137 19 476 Depreciation of rental assets -4,559 -3,469 -8,821 -6,800 Other operating expenses -1,669 -1,868 -3,352 -3,326 Cost of assets sold previously rented to customers -4,053 -3,386 -7,696 -7,736 Net rental income/expenses 3,558 3,112 7,091 6,044 Net gains/losses from financial assets measured at fair value -463 305 -19 1,195 Foreign exchange rate gain/losses 39 557 58 218 Net gain/losses from financial items -424 862 39 1,413 Total net income 20,739 19,133 41,470 36,697 Personnel expenses -5,759 -4,922 -11,369 -9,693 Marketing expenses -1,034 -704 -1,887 -1,337 Administrative expenses -3,066 -3,187 -6,028 -6,025 Depreciation, amortization -1,739 -2,018 -3,402 -3,774 Total operating expenses -11,598 -10,831 -22,686 -20,829 Impairment losses on loans and receivables -4,875 -4,127 -9,345 -7,326 Profit before income tax 4,266 4,175 9,439 8,542 Income tax expense -702 -398 -1,344 -801 Profit for the period 3,564 3,777 8,095 7,741 Other comprehensive income that may be reclassified subsequently to profit or loss Currency translation differences -32 -277 -139 -257 Total comprehensive income for the period 3,532 3,500 7,956 7,484 Consolidated statement of financial position (in thousands of euros) 30.06.2025 31.12.2024 Assets Cash and cash equivalents 162,628 153,191 Mandatory reserves at central banks 26,687 25,156 Investments in debt securities 47,447 46,724 Financial assets measured at fair value through profit or loss 0 27 Loans and receivables 1,088,936 1,041,542 Other financial assets 5,829 4,569 Tangible fixed assets 102,110 98,069 Right of use assets 21,241 20,551 Intangible assets 32,557 31,560 Other assets 6,706 9,718 Deferred tax assets 5,218 4,707 Total assets 1,499,359 1,435,814 Liabilities Customer deposits 1,233,383 1,171,359 Financial liabilities measured at fair value through profit or loss 687 503 Other financial liabilities 63,050 59,135 Current tax liability 529 62 Deferred tax liability 878 533 Other liabilities 4,242 4,620 Subordinated debt securities 40,911 52,046 Total liabilities 1,343,680 1,288,258 Equity Share capital 1,152 1,152 Share premium 54,849 54,849 Statutory reserve 115 109 Other reserves 1,357 1,329 Retained earnings 98,206 90,117 Total equity 155,679 147,556 Total liabilities and equity 1,499,359 1,435,814Inbank is a financial technology company with an EU banking license that connects merchants, consumers and financial institutions on its next generation embedded finance platform. Partnering with more than 5,700 merchants, Inbank has 931,000+ active contracts and collects deposits across 7 markets in Europe. Inbank bonds are listed on the Nasdaq Tallinn Stock Exchange. Additional information:Styv SolovjovAS InbankHead of Investor Relations+372 5645 Inbank_Interim_Report_2025_Q2 Inbank_Corporate_Presentation_Q2_2025
Yahoo
25 minutes ago
- Yahoo
Asian Market Value Picks: 3 Companies That May Be Trading Below Intrinsic Estimates
Amidst global economic uncertainties and fluctuating trade policies, Asian markets have shown resilience, with varying impacts on indices across the region. This environment presents opportunities for discerning investors to explore stocks that may be trading below their intrinsic value, particularly those with strong fundamentals and potential for growth despite external pressures. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Xi'an NovaStar Tech (SZSE:301589) CN¥155.51 CN¥309.46 49.7% SpiderPlus (TSE:4192) ¥506.00 ¥997.79 49.3% Ningbo Sanxing Medical ElectricLtd (SHSE:601567) CN¥22.88 CN¥45.72 50% Nanya Technology (TWSE:2408) NT$43.75 NT$87.13 49.8% Nan Ya Printed Circuit Board (TWSE:8046) NT$176.50 NT$350.51 49.6% Insource (TSE:6200) ¥926.00 ¥1843.53 49.8% H.U. Group Holdings (TSE:4544) ¥3254.00 ¥6446.96 49.5% Elan (TSE:6099) ¥850.00 ¥1696.06 49.9% cottaLTD (TSE:3359) ¥441.00 ¥871.25 49.4% Astroscale Holdings (TSE:186A) ¥676.00 ¥1333.68 49.3% Click here to see the full list of 274 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Beijing HyperStrong Technology Overview: Beijing HyperStrong Technology Co., Ltd. designs, develops, integrates, and operates energy storage power stations across China, Europe, North America, and Australia with a market cap of CN¥16.64 billion. Operations: The company's revenue segments include the design, development, integration, and operation of energy storage power stations across its key markets in China, Europe, North America, and Australia. Estimated Discount To Fair Value: 37.2% Beijing HyperStrong Technology is trading at CN¥92.37, significantly below its estimated fair value of CN¥147.06, suggesting it may be undervalued based on cash flows. Its revenue and earnings are forecast to grow over 30% annually, outpacing the Chinese market's growth rates. However, its dividend yield of 1.19% is not well covered by free cash flows. Recent innovations like the HyperBlock M enhance its competitive edge in energy storage solutions through modularity and efficiency improvements. Upon reviewing our latest growth report, Beijing HyperStrong Technology's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of Beijing HyperStrong Technology stock in this financial health report. Shenzhen KSTAR Science and Technology Overview: Shenzhen KSTAR Science and Technology Co., Ltd. operates in the technology sector, focusing on power electronics and renewable energy solutions, with a market cap of CN¥13.86 billion. Operations: Unfortunately, the provided text does not contain specific revenue segment information for Shenzhen KSTAR Science and Technology Co., Ltd. Estimated Discount To Fair Value: 48.5% Shenzhen KSTAR Science and Technology is trading at CN¥23.8, well below its estimated fair value of CN¥46.24, indicating potential undervaluation based on cash flows. The company's revenue is projected to grow 22.3% annually, surpassing the Chinese market's average growth rate. Despite a forecasted earnings growth of 32.4%, profit margins have declined from last year, and the dividend track record remains unstable with recent reductions in payouts for 2024 dividends. The growth report we've compiled suggests that Shenzhen KSTAR Science and Technology's future prospects could be on the up. Click here to discover the nuances of Shenzhen KSTAR Science and Technology with our detailed financial health report. Qingdao Baheal Medical Overview: Qingdao Baheal Medical INC. is involved in the research, development, production, wholesale, and retail of pharmaceutical products across China, the United States, Hong Kong, and the United Kingdom with a market cap of CN¥11.77 billion. Operations: Qingdao Baheal Medical INC. generates revenue through its activities in the research, development, production, wholesale, and retail sectors of pharmaceutical products across several international markets including China, the United States, Hong Kong, and the United Kingdom. Estimated Discount To Fair Value: 18.5% Qingdao Baheal Medical, trading at CN¥22.39, is priced below its fair value estimate of CN¥27.46, reflecting potential undervaluation based on cash flows. Despite a volatile share price recently, earnings are projected to grow significantly at 20.05% annually over the next three years, although this lags behind the broader Chinese market's growth rate. The company affirmed a dividend payout for 2024, which may appeal to income-focused investors amid stable revenue growth projections of 13% per year. In light of our recent growth report, it seems possible that Qingdao Baheal Medical's financial performance will exceed current levels. Click here and access our complete balance sheet health report to understand the dynamics of Qingdao Baheal Medical. Turning Ideas Into Actions Unlock more gems! Our Undervalued Asian Stocks Based On Cash Flows screener has unearthed 271 more companies for you to here to unveil our expertly curated list of 274 Undervalued Asian Stocks Based On Cash Flows. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:688411 SZSE:002518 and SZSE:301015. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Glomac Berhad (KLSE:GLOMAC) shareholders have endured a 13% loss from investing in the stock a year ago
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. For example, the Glomac Berhad (KLSE:GLOMAC) share price is down 18% in the last year. That's well below the market decline of 1.8%. The silver lining (for longer term investors) is that the stock is still 1.7% higher than it was three years ago. Furthermore, it's down 12% in about a quarter. That's not much fun for holders. Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Unfortunately Glomac Berhad reported an EPS drop of 34% for the last year. The share price fall of 18% isn't as bad as the reduction in earnings per share. So despite the weak per-share profits, some investors are probably relieved the situation wasn't more difficult. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. It might be well worthwhile taking a look at our free report on Glomac Berhad's earnings, revenue and cash flow. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for Glomac Berhad the TSR over the last 1 year was -13%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 1.8% in the last year, Glomac Berhad shareholders lost 13% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 5%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Glomac Berhad is showing 2 warning signs in our investment analysis , you should know about... Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data